Financial Statements — INCR
Balance Sheet
(in millions ILS)| Metric | FY
2024 | FY
2023 | FY
2022 | FY
2021 |
|---|
| Cash & Equivalents | 78.32 | 101.14 | 232.59 | 196.22 |
| Inventory | 120.31 | 105.47 | 120.13 | 62.31 |
| Total Current Assets | 391.80 | 418.80 | 507.49 | 336.16 |
| Goodwill | 224.59 | 221.08 | 284.18 | 258.07 |
| Total Non-current Assets | 370.77 | 367.81 | 450.51 | 350.16 |
| Total Assets | 762.57 | 786.61 | 958.01 | 686.32 |
| Total Current Liabilities | 226.75 | 225.87 | 312.72 | 193.59 |
| Total Non-current Liabilities | 138.15 | 103.68 | 123.81 | 33.55 |
| Total Liabilities | 364.90 | 329.55 | 436.53 | 227.13 |
| Retained Earnings | (277.58) | (203.99) | (141.65) | (186.47) |
| Total Stockholder Equity | 397.67 | 457.06 | 521.48 | 459.19 |
Income Statement
(in millions ILS) (except per-share rows)| Metric | FY
2024 | FY
2023 | FY
2022 | FY
2021 |
|---|
| Total Revenue | 238.85 | 355.55 | 388.68 | 219.68 |
| Cost of Revenue* | 208.61 | 250.46 | 233.60 | 128.55 |
| Gross Profit | 30.23 | 105.10 | 155.08 | 91.13 |
| Research & Development | 0.41 | 0.39 | 0.63 | 1.24 |
| Selling, General & Admin | 53.67 | 42.61 | 36.08 | 27.21 |
| Total Operating Expenses* | 97.44 | 146.66 | 104.46 | 62.95 |
| Operating Income | (67.21) | (41.57) | 50.63 | 28.19 |
| Pretax Income | (87.32) | (61.28) | 43.84 | 18.73 |
| Tax Provision | (14.53) | 2.25 | 0.09 | 11.44 |
| Net Income | (72.79) | (63.53) | 43.75 | 7.29 |
| Basic EPS | (7.40) | (6.80) | 4.95 | 0.60 |
| Diluted EPS | (7.40) | (6.80) | 4.95 | 0.55 |
* Derived from reported values
Cash Flow Statement
(in millions ILS)| Metric | FY
2024 | FY
2023 | FY
2022 | FY
2021 |
|---|
| Operating Cash Flow | (66.93) | (53.63) | 51.27 | 25.02 |
| Investing Cash Flow | 17.69 | 4.77 | (142.50) | (65.21) |
| Financing Cash Flow | 26.46 | (82.89) | 120.45 | 203.06 |
